These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1511063)

  • 1. Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
    Gutensohn K; Weh HJ; Walter TA; Hossfeld DK
    Ann Hematol; 1992 Aug; 65(2):88-90. PubMed ID: 1511063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyotype in multiple myeloma and plasma cell leukaemia.
    Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
    Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
    Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC amplification on double minute chromosomes in plasma cell leukemia with double IGH/CCND1 fusion genes.
    Yamamoto K; Yakushijin K; Ito M; Goto H; Higashime A; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Cancer Genet; 2020 Apr; 242():35-40. PubMed ID: 32035866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia.
    Lloveras E; Granada I; Zamora L; Espinet B; Florensa L; Besses C; Xandri M; Pérez-Vila ME; Millà F; Woessner S; Solé F
    Cancer Genet Cytogenet; 2004 Jan; 148(1):71-6. PubMed ID: 14697644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome studies in myelomatosis.
    Wurster-Hill DH; McIntyre OR; Cornwell GG
    Virchows Arch B Cell Pathol; 1978 Nov; 29(1-2):93-7. PubMed ID: 103316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar cytogenetic abnormalities in two cases of plasma cell leukemia.
    Smadja N; Krulik M; Louvet C; de Gramont A; Gonzalez-Canali G; Mougeot-Martin M
    Cancer Genet Cytogenet; 1991 Mar; 52(1):123-9. PubMed ID: 2009507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.
    Dewald GW; Kyle RA; Hicks GA; Greipp PR
    Blood; 1985 Aug; 66(2):380-90. PubMed ID: 3926026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
    Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
    Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E
    Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.
    Nowotny H; Karlic H; Grüner H; Hirsch J; Vesely M; Nader A; Heinz R
    Ann Hematol; 1996 May; 72(5):291-301. PubMed ID: 8645741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic study of multiple myeloma].
    Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of G banded karyotypes in myeloma cells.
    Chen KC; Bevan PC; Matthews JG
    J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.
    Avet-Loiseau H; Facon T; Grosbois B; Magrangeas F; Rapp MJ; Harousseau JL; Minvielle S; Bataille R;
    Blood; 2002 Mar; 99(6):2185-91. PubMed ID: 11877296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].
    Fukushima Y; Miura I; Niitsu H; Hashimoto K; Takatsu H; Akihama T; Miura A
    Rinsho Ketsueki; 1986 Nov; 27(11):2124-30. PubMed ID: 3820630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.